Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

216.88
BATS BZX Real-Time Price
As of 9:35am ET
 +2.57 / +1.20%
Today’s Change
145.12
Today|||52-Week Range
242.37
+17.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$31.6B

Company Description

Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function. The company provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing services. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Contact Information

Illumina, Inc.
5200 Illumina Way
San Diego California 92122
P:(858) 202-4500
Investor Relations:
(858) 255-5243

Employees

Shareholders

Individual stakeholders6.57%
Mutual fund holders50.04%
Other institutional45.88%

Top Executives

Jay T. FlatleyChief Executive Officer & Director
Francis A. deSouzaPresident & Director
Robert P. RagusaSenior Vice President-Global Quality & Operations
Marc A. StapleyChief Financial Officer & Senior Vice President
Mostafa RonaghiChief Technology Officer & Senior Vice President